BSE Live
Jan 23, 16:01Prev. Close
1485.60
Open Price
1485.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:45Prev. Close
1485.60
Open Price
1493.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1462.80 (19)
| Cash Flow of Ipca Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 361.08 | 630.59 | 454.27 | 364.31 | 340.69 | |
| Net CashFlow From Operating Activities | 455.29 | 534.59 | 388.77 | 278.33 | 214.20 | |
| Net Cash Used In Investing Activities | -676.40 | -381.31 | -262.37 | -285.90 | -198.10 | |
| Net Cash Used From Financing Activities | 250.54 | -136.13 | -80.43 | 3.70 | -17.75 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.41 | 0.00 | 5.45 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 29.43 | 17.56 | 45.97 | 1.58 | -1.65 | |
| Cash And Cash Equivalents Begin of Year | 74.25 | 56.69 | 10.72 | 9.14 | 10.79 | |
| Cash And Cash Equivalents End Of Year | 103.68 | 74.25 | 56.69 | 10.72 | 9.14 |
23.01.2026
12.01.2026
11.01.2026
05.12.2025
26.11.2025
Ipca Labs Consolidated September 2025 Net Sales at Rs 2,556.50 crore, up 8.56% Y-o-Y
24.11.2025
Ipca Labs Standalone September 2025 Net Sales at Rs 1,930.32 crore, up 6.59% Y-o-Y
05.09.2025
Ipca Labs Standalone June 2025 Net Sales at Rs 1,746.90 crore, up 11.56% Y-o-Y
10.06.2025
Ipca Labs Standalone March 2025 Net Sales at Rs 1,638.44 crore, up 8.46% Y-o-Y
13.07.2022
Ipca Lab Q1 PAT may dip 41.4% YoY to Rs 179.8 cr: ICICI Direct
08.07.2022
Ipca Laboratories Q1 PAT may dip 36.5% YoY to Rs 194.9 cr: Prabhudas Lilladher
14.04.2022
Ipca Laboratories Q4 PAT may dip 12% YoY to Rs 141.9 cr: Prabhudas Lilladher
13.01.2022
Ipca Laboratories Q3 PAT may dip 32.4% YoY to Rs 179.6 cr: Prabhudas Lilladher